Axillary lymph node count is lower after neoadjuvant chemotherapy

American Journal of Surgery

Volumn 191, Issue 6, 2006, Pages 827-829

  Neuman, Heather ^a   Carey, Lisa A ^a   Ollila, David W ^a   Livasy, Chad ^a   Calvo, Benjamin F ^a   Meyer, Anthony A ^a   Kim, Hong Jin ^a   Meyers, Michael O ^a   Dees, E Claire ^a   Collichio, Fran A ^a   Sartor, Carolyn I ^a   Moore, Dominic T ^b,c   Sawyer, Lynda R ^c   Frank, Jill ^a   Klauber DeMore, Nancy ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b IL   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Axillary lymph node dissection; Breast cancer; Locally advanced breast cancer; Lymph node retrieval

Indexed keywords

ANTHRACYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; TAXANE DERIVATIVE; TRASTUZUMAB;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MASTECTOMY; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 33646565997     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2005.08.041     Document Type: Article

References (9)

1. Danforth Jr. D.N., Findlay P.A., McDonald H.D., et al. Complete axillary lymph node dissection for stage I-II carcinoma of the breast. J Clin Oncol 4 (1986) 655-662
2. Kiricuta C.I., and Tausch J. A mathematical model of axillary lymph node involvement based on 1446 complete axillary dissections in patients with breast carcinoma. Cancer 69 (1992) 2496-2501
3. Somner J.E., Dixon J.M., and Thomas J.S. Node retrieval in axillary lymph node dissections. recommendations for minimum numbers to be confident about node negative status. J Clin Pathol 57 (2004) 845-848
4. Ollila D.W., Neuman H.B., Sartor C.I., et al. Lymphatic mapping and sentinel lymphadenectomy prior to neoadjuvant chemotherapy in patients with large breast cancers. Am J Surg 190 (2005) 371-375
5. Schaapveld M., Otter R., De Vries E.G., et al. Variability in axillary lymph node dissection for breast cancer. J Surg Oncol 87 (2004) 4-12
6. van der Wal B.C., Butzelaar R.M., van der M.S., et al. Axillary lymph node ratio and total number of removed lymph nodes. predictors of survival in stage I and II breast cancer. Eur J Surg Oncol 28 (2002) 481-489
7. Fisher B., Bryant J., Wolmark N., et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16 (1998) 2672-2685
8. Newman L.A., Pernick N.L., Adsay V., et al. Histopathologic evidence of tumor regression in the axillary lymph nodes of patients treated with preoperative chemotherapy correlates with breast cancer outcome. Ann Surg Oncol 10 (2003) 734-739
9. Petrik D.W., McCready D.R., Sawka C.A., et al. Association between extent of axillary lymph node dissection and patient, tumor, surgeon, and hospital factors in patients with early breast cancer. J Surg Oncol 82 (2003) 84-90